# Geron (stock symbol: GERN) Logo in transparent PNG and SVG formats

## Geron Logo large

### Geron Logo large Download PNG (47 KB)

![Geron Logo large Download PNG (47 KB)](/img/orig/GERN_BIG-39e10d38.png)

### Geron Logo large Download SVG (5.01 KB)

![Geron Logo large Download SVG (5.01 KB)](/img/orig/GERN_BIG-8647a91b.svg)

## Geron Logo icon format

### Geron Logo icon format Download PNG (58.28 KB)

![Geron Logo icon format Download PNG (58.28 KB)](/img/orig/GERN-256e436e.png)

### Geron Logo icon format Download SVG (1.95 KB)

![Geron Logo icon format Download SVG (1.95 KB)](/img/orig/GERN-553d2436.svg)

## Geron Logo large for dark backgrounds

### Geron Logo large for dark backgrounds Download PNG (29.66 KB)

![Geron Logo large for dark backgrounds Download PNG (29.66 KB)](/img/orig/GERN_BIG.D-5669c80f.png)

### Geron Logo large for dark backgrounds Download SVG (4.94 KB)

![Geron Logo large for dark backgrounds Download SVG (4.94 KB)](/img/orig/GERN_BIG.D-1d4dcca7.svg)

## Geron Logo icon format for dark backgrounds

### Geron Logo icon format for dark backgrounds Download PNG (35.57 KB)

![Geron Logo icon format for dark backgrounds Download PNG (35.57 KB)](/img/orig/GERN.D-3f99929f.png)

### Geron Logo icon format for dark backgrounds Download SVG (1.87 KB)

![Geron Logo icon format for dark backgrounds Download SVG (1.87 KB)](/img/orig/GERN.D-8d14380e.svg)

## About Geron

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

1. Website domain: geron.com
2. Employees: 69
3. Marketcap: $1.25 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
